Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Desquamation

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44335   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    29 result(s) found for: Desquamation. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2006-005242-36 Sponsor Protocol Number: K40-3 Start Date*: 2006-12-13
    Sponsor Name:Moberg Derma AB
    Full Title: A multicenter, randomised, double-blind, placebo-controlled clinical study evaluating efficacy, safety and tolerability of topical K40 in 8 weeks treatment of adult patients with moderate to severe...
    Medical condition: Seborrhoeic Dermatitis of the scalp.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10039794 Seborrhoeic dermatitis capitis LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2010-024033-24 Sponsor Protocol Number: 11-01/BSal-L Start Date*: 2011-05-31
    Sponsor Name:Dermapharm AG
    Full Title: Doppelblinde, randomisierte klinische Studie zum Vergleich der Wirksamkeit und Verträglichkeit von Betamethason 0,05%_Salicylsäure 2% Lösung vs. Diprosalic Lösung vs. Grundlage bei Patienten mit Ps...
    Medical condition: Psoriasis capitis
    Disease: Version SOC Term Classification Code Term Level
    14.1 100000004858 10037157 Psoriasis of scalp LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2016-001106-42 Sponsor Protocol Number: 16-01/CalciBet-Gel Start Date*: 2016-09-19
    Sponsor Name:Dermapharm AG
    Full Title: Double-blind, randomised clinical study comparing efficacy and safety of Calcipotriol 50 µg/g_Betamethasone 0.5 mg/g Gel (Test) vs. Daivobet(R) Gel (Reference) vs. Vehicle in patients with scalp ps...
    Medical condition: Psoriasis capitis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000018190 10037157 Psoriasis of scalp LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2007-006188-59 Sponsor Protocol Number: K301-1 Start Date*: 2008-01-14
    Sponsor Name:Moberg Derma AB
    Full Title: A multicenter, randomised double blind, placebo-controlled study of efficacy, safety and tolerability of Kaprolac® K301 for the treatment of seborrhoeic eczema (SE) of the scalp.
    Medical condition: seborrhoeic dermatitis of the scalp
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039794 Seborrhoeic dermatitis capitis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: View results
    EudraCT Number: 2005-004852-11 Sponsor Protocol Number: BT0400-207-INT Start Date*: 2006-02-07
    Sponsor Name:Barrier Therapeutics Inc.
    Full Title: A double-blind, randomized, placebo-controlled, dose finding study of R126638 given as a single or repeat dose in oral solution vs placebo in the treatment of pityriasis versicolor.
    Medical condition: Pityriasis versicolor / Tinea versicolor
    Disease: Version SOC Term Classification Code Term Level
    8.1 10056227 Pityriasis versicolour LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-013656-77 Sponsor Protocol Number: 09-PP-02 Start Date*: 2009-10-15
    Sponsor Name:Nice University Hospital
    Full Title: Traitment of recessive nonbullous congenital ichthyosis with topic Epigallocatechin.
    Medical condition: Recessive nonbullous congenital ichthyosis
    Disease: Version SOC Term Classification Code Term Level
    12.0 10021197 Ichthyoses HLT
    Population Age: Children, Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: View results
    EudraCT Number: 2019-003601-10 Sponsor Protocol Number: NL69300 Start Date*: 2020-09-18
    Sponsor Name:Amsterdam University Medical Centers
    Full Title: Treatment of Skin Severity in Ichthyosis with Hyperbaric Oxygen Therapy
    Medical condition: ichthyosis
    Disease: Version SOC Term Classification Code Term Level
    20.0 10010331 - Congenital, familial and genetic disorders 10021198 Ichthyosis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2004-003835-30 Sponsor Protocol Number: Start Date*: 2005-05-26
    Sponsor Name:Belfast City Hospital
    Full Title: An open label, single centre, assessor blind pilot study comparing topical tacrolimus 0.1% and hydrocortisone ointment 1% in the treatment of flexural psoriasis
    Medical condition: flexural psoriasis
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: GB (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2008-004695-49 Sponsor Protocol Number: 08-01 / Ter-C Start Date*: 2009-01-13
    Sponsor Name:Dermapharm AG
    Full Title: Doppelblinde, randomisierte klinische Studie zum Vergleich der Wirksamkeit und Verträglichkeit von Terbinafin Creme 1% vs. Lamisil® Creme vs. Grundlage bei Patienten mit Tinea pedis
    Medical condition: Tinea pedis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10043873 Tinea pedis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-002783-27 Sponsor Protocol Number: KAWA2019-1962 Start Date*: 2020-03-04
    Sponsor Name:Amsterdam University Medical Center
    Full Title: A 12-month, open-label, parallel-cohort study to evaluate the efficacy, safety and tolerability of Canakinumab in Kawasaki disease
    Medical condition: Active Kawasaki disease
    Disease: Version SOC Term Classification Code Term Level
    20.0 10047065 - Vascular disorders 10023320 Kawasaki's disease PT
    Population Age: Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: NL (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2006-006601-83 Sponsor Protocol Number: P04481 Start Date*: 2007-05-14
    Sponsor Name:Schering-Plough Research Institute, a division of Schering Corp.
    Full Title: A Study to Assess the Clinical Effects of SCH 527123 in Psoriasis.
    Medical condition: Psoriasis
    Disease: Version SOC Term Classification Code Term Level
    9.1 10037153 Psoriasis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2009-013120-23 Sponsor Protocol Number: 200802.2.45 Start Date*: 2009-09-11
    Sponsor Name:LABCATAL
    Full Title: Efficacité et tolérance du LBC 45 dans la dermite séborrhéique du cuir chevelu
    Medical condition: Dermite séborrhéique du cuir chevelu
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022861-93 Sponsor Protocol Number: 201003.2.45 Start Date*: 2010-10-28
    Sponsor Name:Laboratoire LABCATAL
    Full Title: Confirmation de l'efficacité et de la tolérance du LBC 45 dans la dermite séborrhéique du cuir chevelu
    Medical condition: Dermite séborrhéique du cuir chevelu
    Disease: Version SOC Term Classification Code Term Level
    9.1 10039788 LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: FR (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2007-005795-13 Sponsor Protocol Number: Ketoil 01/07 Start Date*: 2007-11-12
    Sponsor Name:MIPHARM
    Full Title: EFFICACY AND SAFETY ASSESSMENT OF KETOIL, SHAMPOO CONTAINING KETOCONAZOLE 0.5% SERENOA REPENS (SAW PALM) AND TAURINE, IN THE TREATMENT OF PATIENTS AFFECTED BY DANDRUFF AND SEBORRHEIC DERMATITIS COM...
    Medical condition: dandruff and seborroic dermatitis
    Disease: Version SOC Term Classification Code Term Level
    6.1 10050909 PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005573-36 Sponsor Protocol Number: DC0120LE202 Start Date*: 2015-06-18
    Sponsor Name:Pierre Fabre Dermatologie represented by the Institut de Recherche Pierre Fabre (IRPF)
    Full Title: Assessment of the efficacy of a new formulation of minoxidil (DC120) on hair growth, in a minizone model in androgenetic alopecia in men
    Medical condition: androgenetic alopecia
    Disease:
    Population Age: Adults Gender: Male
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-001419-21 Sponsor Protocol Number: RC19_0042 Start Date*: 2019-09-16
    Sponsor Name:CHU de Nantes
    Full Title: Optimization of skin preparation to reduce Cutibacterium acnes colonization in superficial and deep samples during prosthetic shoulder surgery in male patients
    Medical condition: Cutibacterium acnes infection in shoulder arthroplasty with males
    Disease:
    Population Age: Adults, Elderly Gender: Male
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2010-022843-39 Sponsor Protocol Number: ATN117221 Start Date*: 2011-04-08
    Sponsor Name:GlaxoSmithKline R&D Ltd
    Full Title: Efficacy of oral alitretinoin treatment in patients with palmo-plantar pustulosis (PPP) inadequately responding to standard topical treatment
    Medical condition: Palmo-Plantar Pustulosis
    Disease: Version SOC Term Classification Code Term Level
    16.0 100000004858 10050185 Palmoplantar pustulosis LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) GB (Completed) NL (Completed)
    Trial results: View results
    EudraCT Number: 2019-002851-40 Sponsor Protocol Number: CLOTAIS01/2019 Start Date*: 2020-08-27
    Sponsor Name:ANTIBIOTICE SA
    Full Title: A Randomized, Parallel Design, Multiple-Site Study to Evaluate the non-inferiority of generic Clotrimazole 10mg/g cream (Antibiotice SA) compared to Canesten® 10mg/g cream in Patients with Tinea Pedis
    Medical condition: Tinea Pedis
    Disease: Version SOC Term Classification Code Term Level
    21.1 10021881 - Infections and infestations 10043873 Tinea pedis PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: RO (Trial now transitioned) HU (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-004052-20 Sponsor Protocol Number: CKTO 2005-25R Start Date*: 2006-11-01
    Sponsor Name:Koningin Wilhelmina Fonds
    Full Title: Phase II study of definitive radiochemotherapy for locally advanced squamous cell cancer of the vulva: an efficacy study
    Medical condition: advanced stage squamous cell cancer of the vulva
    Disease: Version SOC Term Classification Code Term Level
    8.1 10047777 Vulvar cancer LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2021-003785-13 Sponsor Protocol Number: KTDIIS02 Start Date*: 2021-11-19
    Sponsor Name:Karolinska Universitetssjukhuset
    Full Title: An investigator-initiated, open label trial to investigate efficacy of brodalumab in eczematized psoriasis (BRodalumab in Eczematized PSOriasis)
    Medical condition: eczematized psoriasis
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 15 05:42:41 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA